REMEDOR BIOMED LTD has a total of 24 patent applications. Its first patent ever was published in 2008. It filed its patents most often in United States, EPO (European Patent Office) and Israel. Its main competitors in its focus markets pharmaceuticals, organic fine chemistry and medical technology are ORIGIN BIOMED INC, MARCHEWITZ ERIC and DAIICHI SANKYO HEALTHCARE CO LTD.
# | Country | Total Patents | |
---|---|---|---|
#1 | United States | 8 | |
#2 | EPO (European Patent Office) | 3 | |
#3 | Israel | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 3 | |
#5 | China | 2 | |
#6 | Australia | 1 | |
#7 | Canada | 1 | |
#8 | Hong Kong | 1 | |
#9 | Japan | 1 | |
#10 | Republic of Korea | 1 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Organic fine chemistry | |
#3 | Medical technology |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Specific use of cosmetics | |
#4 | Implantable devices |
# | Name | Total Patents |
---|---|---|
#1 | Hamed Saher | 21 |
#2 | Saher Hamed | 2 |
Publication | Filing date | Title |
---|---|---|
CN107427559A | Part erythropoietin preparation and the method and its beautifying use with its raising wound healing | |
WO2011104707A1 | Methods and compositions for enhancing fat graft survival | |
IL207113D0 | Erythropietin and fibronectin compositions for bone regeneration | |
IL203964A | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications | |
EP2268301A2 | Erythropoietin and fibronectin compositions for bone regeneration | |
US2011123481A1 | Erythropoietin and fibronectin compositions for therapeutic and cosmetic applications |